First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/M cervical cancer

Special issue on real world breast cancer data

Trial investigates multiparametric prognostic score in early HR+/HER2- breast cancer

Chairperson: Evidence Communication

Patient benefit vs industry benefit finding a balance

Haemato-oncological Cancers

Hope vs Hype of evidence interpretation

Shared decision making (Patient-oncologist)

Panelist - Patient Advocacy Panel discussion

Real world evidence research – asking the right question

Improving design of clinical trials

Patient advocacy – the right communication